Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Perrigo Company    PRGO   US7142901039

PERRIGO COMPANY (PRGO)

6
 SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Company
Perrigo Co. plc is a global healthcare supplier.It develops, manufactures and distributes over-the-counter and prescription pharmaceuticals, nutritional products, and active pharmaceutical ingredients.The company was formed as a part of merger between Perrigo Co. and Elan Corp. Plc as on December... 
Sector
Pharmaceuticals
Calendar
02/03Earnings Release
More about the company
Surperformance© ratings of Perrigo Company
Trading Rating : Investor Rating :
More Ratings
Financials ($)
Sales 2015 4 455 M
EBIT 2015 1 293 M
Net income 2015 741 M
Debt 2015 1 489 M
Yield 2015 0,31%
Sales 2016 4 797 M
EBIT 2016 1 488 M
Net income 2016 969 M
Debt 2016 556 M
Yield 2016 0,33%
PER 2015 28,14
PER 2016 22,28
EV / Sales 2015 5,54x
EV / Sales 2016 4,95x
Capitalization 23 207 M
More Financials
Latest news on PERRIGO COMPANY
12/02 PERRIGO : Announces FDA Approval And Launch Of The Generic Version Of Pennsaid® ..
11/28 Germany's Merck aims to grow, not sell $1 billion consumer health arm
11/25 PERRIGO COMPANY PLC : ex-dividend day
11/04 SAC's Martoma wins delay of 9-year insider trading prison term
11/04 PERRIGO : Financial Results, Appointments, and Upcoming Conference Calls - Resea..
11/03PERRIGO COMPANY PLC : quaterly earnings release
10/20 Actavis, Sanofi among bidders for Omega Pharma- Bloomberg
09/10 PERRIGO : Pharma Equities Technical Coverage - VIVUS, Auxilium Pharma, Depomed, ..
More news
Sector news
1d ago JAZZ PHARMACEUTICALS : Receives FDA Approval For Intravenous Administration Of E..
1d ago CUBIST PHARMACEUTICALS : FDA OKs Cubist antibiotic for serious infections
1d ago CUBIST PHARMACEUTICALS : Announces FDA Approval of New Antibiotic ZERBAXA™..
More sector news
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF